| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/03/2001 | US6211334 Cell-cycle regulatory proteins, and uses related thereto |
| 04/03/2001 | US6211162 Pulmonary delivery of protonated/acidified nucleic acids |
| 04/03/2001 | US6210949 Nucleotide sequences coding tumor suppressor proteins; for the diagnosis and treatment of cancer; anticarcinogenic agents |
| 04/03/2001 | US6210941 Methods for the detection and isolation of proteins |
| 04/03/2001 | US6210894 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 04/03/2001 | US6210885 Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography |
| 04/03/2001 | US6210707 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 04/03/2001 | US6210654 Jak kinases and regulation of cytokine signal transduction |
| 04/03/2001 | CA2163755C Dna encoding prostaglandin receptor ep1 |
| 04/03/2001 | CA2153180C Interleukin 4 signal transducers and binding assays |
| 04/03/2001 | CA2066234C Activation compounds and methods for nucleic acid sterilization |
| 03/29/2001 | WO2001021838A2 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 03/29/2001 | WO2001021653A2 Ovarian tumor antigen and methods of use therefor |
| 03/29/2001 | WO2001021637A1 Light-responsive oligonucleotide |
| 03/29/2001 | WO2001021635A2 Method for electrochemically detecting sequence-specific nucleic acid-oligomer hybridisation events |
| 03/29/2001 | WO2001021632A1 Method for nucleic acid isolation and kit |
| 03/29/2001 | WO2001000843A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/29/2001 | WO2000032823A9 Dna-protein fusions and uses thereof |
| 03/29/2001 | CA2385851A1 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1086742A1 Combinatorial strategies for polymer synthesis |
| 03/28/2001 | EP1086251A2 Compounds and methods for detecting biomolecules |
| 03/28/2001 | EP1086246A1 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| 03/28/2001 | EP1086245A2 Multi-fluorescent hairpin energy transfer oligonucleotides |
| 03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 03/28/2001 | EP1086205A1 Methods of monitoring disease states and therapies using gene expression profiles |
| 03/28/2001 | EP1086179A1 Energy transfer assay method and reagent |
| 03/28/2001 | EP1086178A1 An anthraquinone and its derivatives |
| 03/28/2001 | EP1086116A1 Compositions and methods for the pulmonary delivery of nucleic acids |
| 03/28/2001 | EP1086115A2 Purines and pyrimidines linked to a quencher |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063755C Oligomeric deoxynucleotide of vascular endothelial cell growth factor |
| 03/27/2001 | US6207819 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds |
| 03/27/2001 | US6207797 Deactivation of reactive species present on surface of copolymer by antiradical chemical treatment, electrochemical treatment to modify the degree of oxidation, and/or rinsing operations using a surfactant |
| 03/27/2001 | US6207649 Nucleoside analogs and uses in treating disease |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207416 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 03/27/2001 | US6207409 Culturing a recombinant cell that has been transformed with an expression vector having a regulatory sequence and a polynucleotide comprising a dna sequence which endcodes geranyl/geranylpyrophosphate of flavobacterium species |
| 03/27/2001 | US6207407 Identification of antibacterial agents |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2046916C Methods and compositions for treatment of cancer using oligonucleotides |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/22/2001 | WO2001020035A2 Methods and compositions for linear isothermal amplification of polynucleotide sequences |
| 03/22/2001 | WO2001020017A2 Metal cluster containing nucleotides and nucleic acids, and intermediates therefor |
| 03/22/2001 | WO2001019868A1 A novel angiogenesis inhibitor |
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019842A1 Subunit optimized fusion proteins |
| 03/22/2001 | WO2001019484A1 Purification device and purification method |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | DE19951715C1 New 18-fluoro-labeled cytosine derivatives, useful as tracers for monitoring activity of transferred cytosine deaminase genes in gene therapy of tumors |
| 03/22/2001 | CA2388747A1 Purification device and purification method |
| 03/22/2001 | CA2384860A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | CA2384766A1 Subunit optimized fusion proteins |
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
| 03/21/2001 | EP1084277A2 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components |
| 03/21/2001 | EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1084272A1 Heteroduplex mutational vectors and use thereof in bacteria |
| 03/21/2001 | EP1084245A1 Human receptor tyrosine kinase |
| 03/21/2001 | EP1084134A1 Activators for oligonucleotide synthesis |
| 03/21/2001 | EP0979233A4 Method for solution phase synthesis of oligonucleotides |
| 03/21/2001 | CN1288012A Antisense nucleic acid pointing at urokinase type plasminogen activating agent gene for inhibiting carcer |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204027 Hammerhead ribozyme of defined rna sequence; has increased catalytic activity without reduction in specificity |
| 03/20/2001 | US6203758 An arrangement of individually addressable micro-electrodes for performing biological, synthetic and diagnostic reactions such as nucleic acid hybridization, or antibody-antigen reactions; preperation of carbonhydrate polymers |
| 03/15/2001 | WO2001018524A2 Methods for improving signal detection from an array |
| 03/15/2001 | WO2001018232A2 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001018017A1 Methods for detecting and enumerating campylobacter jejuni in environmental samples and for identifying antibiotic-resistant strains |
| 03/15/2001 | WO2001018015A1 Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/14/2001 | EP1082462A1 Identification of molecular interaction sites in rna for novel drug discovery |
| 03/14/2001 | EP1082444A1 Adeno-associated virus vectors and uses thereof |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082012A1 Novel nucleosides having bicyclic sugar moiety |
| 03/14/2001 | EP0971943A4 Nucleic acid-containing polymerizable complex |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | EP0638089B1 Synthesis of diverse and useful collections of oligonucleotides |
| 03/14/2001 | CN1287689A Affinity based self-assembly systems and devices for photonic and electronic applications |
| 03/14/2001 | CA2300328A1 Modulating transcription of genes in vascular cells |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200792 For bread- or dough-improving composition; reduction in bitter taste of protein hydrolyzates |
| 03/13/2001 | US6200782 Fusion proteins linked to nucleotide sequences; for the preferential adjustment of nucleotide sequences |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200761 Mixture of two nucleic acids |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016372A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/08/2001 | WO2001016369A2 Uv excitable fluorescent energy transfer dyes |
| 03/08/2001 | WO2001016365A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |